ASEAN Capacity for Vaccine Research and Development and Production: Thailand Country Case Study

doi:http://dx.doi.org/10.1596/40377

Publication:
ASEAN Capacity for Vaccine Research and Development and Production: Thailand Country Case Study

dc.contributor.author	World Bank
dc.date.accessioned	2023-09-20T20:29:47Z
dc.date.available	2023-09-20T20:29:47Z
dc.date.issued	2023-06-16
dc.description.abstract	COVID-19 has had a devastating effect on the ASEAN region, which has recorded over 27 million cases of the virus. Access to COVID-19 vaccination has significantly reduced the spread of the disease and limited the number of severe COVID-19 cases, but it has also impacted routine immunization coverage. Countless strategies have been developed to ensure vaccine equity, which were swiftly translated from political assessment to practical action; however, they failed to address the sustained growth of the COVID-19 pandemic and the emergence of variants of concerns, requiring ongoing vaccine booster doses. The pandemic revealed weaknesses in ASEAN's regional vaccine capacity, including in research and development, manufacturing infrastructure and human resources, which made the region particularly vulnerable during COVID-19 surges, as it was highly dependent on vaccine imports. Despite the existence of an established framework for ASEAN collaboration on vaccines, there has been minimal coordination between member states to collectively procure COVID-19 vaccines. Initial consultations with various stakeholders involved in vaccination and equitable access in the ASEAN region highlighted several gaps related to ensuring a sustained supply of quality vaccines throughout the life cycle, as well as several critical areas that require immediate attention. The political commitment to address these issues has been shaped by the evolving pandemic scenarios. The ASEAN Vaccine Security and Self-Reliance (AVSSR) initiative was launched just before the COVID-19 pandemic began and was agreed upon and endorsed by the region's ten leaders during the 34th ASEAN Summit in November 2019. Future regional strategies, policies and plans must ensure consistency with this important ASEAN initiative.	en
dc.identifier	http://documents.worldbank.org/curated/en/099061623000041573/P17809207abd440ae0be820aced53cba398
dc.identifier.doi	10.1596/40377
dc.identifier.uri	https://openknowledge.worldbank.org/handle/10986/40377
dc.language	English
dc.language.iso	en_US
dc.publisher	Washington, DC: World Bank
dc.rights	CC BY-NC 3.0 IGO
dc.rights.holder	World Bank
dc.rights.uri	https://creativecommons.org/licenses/by-nc/3.0/igo
dc.subject	COVID-19
dc.subject	VACCINE
dc.subject	ASEAN REGION
dc.title	ASEAN Capacity for Vaccine Research and Development and Production	en
dc.title.subtitle	Thailand Country Case Study	en
dc.type	Report
dspace.entity.type	Publication
okr.crossref.title	ASEAN Capacity for Vaccine Research and Development and Production: Thailand Country Case Study
okr.date.disclosure	2023-06-16
okr.date.lastmodified	2023-06-15T00:00:00Z	en
okr.doctype	Economic & Sector Work
okr.doctype	Economic & Sector Work::Other Health Study
okr.docurl	http://documents.worldbank.org/curated/en/099061623000041573/P17809207abd440ae0be820aced53cba398
okr.guid	099061623000041573
okr.identifier.docmid	P178092-7abd44c5-721c-46ae-be82-aced53cba398
okr.identifier.doi	http://dx.doi.org/10.1596/40377
okr.identifier.externaldocumentum	34094654
okr.identifier.internaldocumentum	34094654
okr.identifier.report	182882
okr.import.id	1832
okr.imported	true	en
okr.language.supported	en
okr.pdfurl	http://documents.worldbank.org/curated/en/099061623000041573/pdf/P17809207abd440ae0be820aced53cba398.pdf	en
okr.region.administrative	East Asia and Pacific
okr.region.country	Thailand
okr.sector	Health-HG
okr.theme	Health Systems and Policies,Human Development and Gender,Health Finance,Disease Control,Health System Strengthening,Pandemic Response
okr.topic	Health, Nutrition and Population::Immunizations
okr.unit	Health Nutrition &Population EAP (HEAHN)